Skip to Main Content

Advertisement

Skip Nav Destination

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

Blood (2004) 103 (8): 2925–2928.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement